Masibon Liquid (Sodium Alendronate Hydrate)

Adult dose

1 bottle (70 mg of alendronate) once a week in the morning at least 30 minutes before consuming food, beverages, or other medications. Take at least 30 mL or more of water following. After taking, one should not lie down for at least 30 minutes and until after the first food intake. This medication should not be taken before bedtime or upon waking. If a dose is missed, take 1 bottle of 70 mg the next morning.

This medication can irritate the gastrointestinal mucosa, which may lead to problems such as esophagitis or esophageal ulcers, so it must be taken with a sufficient amount of water after ingestion, and one should not lie down for a certain period of time afterwards. It is advisable not to use this medication in patients who have esophageal problems or dysphagia, or who are hypersensitive to this drug. Patients with an allergy to the yellow No. 5 component included in this medication should use it with caution. While taking this drug, gastrointestinal symptoms such as abdominal pain, nausea, dyspepsia, constipation, and diarrhea may occur, and musculoskeletal pain, headache, and dizziness have also been reported. In particular, in patients with osteoporosis, serious side effects such as severe bone pain or osteonecrosis of the jaw may rarely occur, so one should consult a healthcare professional immediately if abnormal symptoms appear. Before taking this medication, it is essential to treat any mineral metabolism disorders, such as hypocalcemia, and it is important to regularly check serum calcium levels during treatment. This medication may inhibit absorption when taken with calcium supplements or antacids, so it should be separated from these medications by at least 30 minutes after taking this drug. During pregnancy, there is a potential risk to the fetus, so it should only be administered under a doctor's judgment, and safety for nursing mothers and children has not been established. Particular caution is needed for the elderly and patients with impaired renal function, and it is not recommended for patients with severe renal failure. In cases of overdose, hypocalcemia and gastrointestinal irritation symptoms may appear, so one should visit a medical institution immediately, and it is important to keep the patient upright without inducing vomiting. This medication should be kept out of reach of children, and transferring it to another container should be avoided.

Serious side effects

Hives, angioedema (severe swelling), esophageal obstruction, esophageal perforation, esophageal stricture, perforation, severe skin adverse reactions (Stevens-Johnson syndrome, toxic epidermal necrolysis), severe allergic reactions, severe swelling, symptoms of hypocalcemia, Stevens-Johnson syndrome, toxic epidermal necrolysis, esophagitis, esophageal erosion, severe gastric ulcers, duodenal ulcers, difficulty breathing (respiratory problems), angioedema, severe allergic reactions

Mild side effects

• Abdominal pain
• nausea
• dyspepsia
• constipation
• diarrhea
• gas
• acid reflux
• esophageal ulcers
• vomiting
• dysphagia

This medication should be stored in a tightly closed container to protect it from air and moisture, preferably at a temperature between 15 to 30 degrees Celsius. Storing it this way helps maintain the efficacy of the medication and prevent deterioration.

Appearance

A transparent bottle containing a liquid with an orange color, flavor, and aroma.

Package unit

100 milliliters/bottle [100ml/bottle × 1 bottle, 100ml/bottle × 4 bottles/box]